Jennifer E. Golden

2.4k total citations
70 papers, 1.4k citations indexed

About

Jennifer E. Golden is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Jennifer E. Golden has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Organic Chemistry and 17 papers in Epidemiology. Recurrent topics in Jennifer E. Golden's work include Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (9 papers) and Advanced Synthetic Organic Chemistry (8 papers). Jennifer E. Golden is often cited by papers focused on Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (9 papers) and Advanced Synthetic Organic Chemistry (8 papers). Jennifer E. Golden collaborates with scholars based in United States, Poland and Canada. Jennifer E. Golden's co-authors include Jeffrey Aubé, Lei Yao, Donghoon Chung, Robert S. Adcock, Chad E. Schroeder, Yong-Kyu Chu, Daniel P. Flaherty, A. G. Maddock, Yibin Zeng and Kevin J. Frankowski and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Geophysical Research Atmospheres.

In The Last Decade

Jennifer E. Golden

69 papers receiving 1.4k citations

Peers

Jennifer E. Golden
Simon A. Osborne United Kingdom
Jennifer E. Golden
Citations per year, relative to Jennifer E. Golden Jennifer E. Golden (= 1×) peers Simon A. Osborne

Countries citing papers authored by Jennifer E. Golden

Since Specialization
Citations

This map shows the geographic impact of Jennifer E. Golden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Golden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Golden more than expected).

Fields of papers citing papers by Jennifer E. Golden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Golden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Golden. The network helps show where Jennifer E. Golden may publish in the future.

Co-authorship network of co-authors of Jennifer E. Golden

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Golden. A scholar is included among the top collaborators of Jennifer E. Golden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Golden. Jennifer E. Golden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Evan P., Yi Xue, Dong Yang, et al.. (2025). Broad spectrum antiviral BDGR-164 provides protection against lethal neurotropic alphavirus infection in mice. Antiviral Research. 240. 106206–106206.
2.
Jonsson, Colleen B., Yi Xue, Peter Vogel, et al.. (2025). The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in mice. Journal of Virology. 99(3). e0167924–e0167924. 1 indexed citations
3.
Guzei, Ilia A., et al.. (2023). Mannich‐Type Condensation and Domino Quinazolinone‐Amidine Rearrangement Affords Ring‐Fused Mackinazolinones with Anti‐Amoebic Activity. Advanced Synthesis & Catalysis. 365(24). 4567–4575. 2 indexed citations
4.
Golden, Jennifer E., et al.. (2023). Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule. Clinical Pharmacokinetics. 62(7). 943–953. 1 indexed citations
5.
Golden, Jennifer E., et al.. (2023). Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses. Viruses. 15(2). 413–413. 6 indexed citations
6.
Ryan, Michael C., Eunjung Kim, Xufeng Cao, et al.. (2022). Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones. ACS Medicinal Chemistry Letters. 13(4). 546–553. 4 indexed citations
7.
Wlodarchak, Nathan, et al.. (2021). Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry. ACS Medicinal Chemistry Letters. 12(2). 228–235. 5 indexed citations
8.
Suryadi, Jimmy, Jan Abendroth, Wesley C. Van Voorhis, et al.. (2019). Enzymatic and Structural Characterization of the Naegleria fowleri Glucokinase. Antimicrobial Agents and Chemotherapy. 63(5). 17 indexed citations
9.
Rane, Digamber, W. Frank An, Samantha Bender, et al.. (2019). Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1. Journal of Medicinal Chemistry. 63(1). 103–121. 34 indexed citations
10.
Golden, Jennifer E., Caleb Marceau, Jan E. Carette, et al.. (2018). Editing N-Glycan Site Occupancy with Small-Molecule Oligosaccharyltransferase Inhibitors. Cell chemical biology. 25(10). 1231–1241.e4. 33 indexed citations
11.
Swingle, Mark R., Claude‐Henry Volmar, S. Adrian Saldanha, et al.. (2016). An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C). SLAS DISCOVERY. 22(1). 21–31. 8 indexed citations
12.
Adcock, Robert S., Yong-Kyu Chu, Jennifer E. Golden, & Donghoon Chung. (2016). Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Antiviral Research. 138. 47–56. 95 indexed citations
13.
Chattopadhyay, Debasish, Mark R. Swingle, E. Alan Salter, et al.. (2016). Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C. Biochemical Pharmacology. 109. 14–26. 25 indexed citations
14.
Shrimal, Shiteshu, Carol Khodier, Daniel P. Flaherty, et al.. (2016). Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nature Chemical Biology. 12(12). 1023–1030. 84 indexed citations
15.
Anayee, Mark, et al.. (2016). Evaluation of substituted ebselen derivatives as potential trypanocidal agents. Bioorganic & Medicinal Chemistry Letters. 27(3). 537–541. 21 indexed citations
16.
Lin, Hong, Yuna Guo, Soumik BasuRay, et al.. (2015). A Pan-GTPase Inhibitor as a Molecular Probe. PLoS ONE. 10(8). e0134317–e0134317. 27 indexed citations
17.
Agola, Jacob O., Hong Lin, Zurab Surviladze, et al.. (2012). A Competitive Nucleotide Binding Inhibitor: In Vitro Characterization of Rab7 GTPase Inhibition. ACS Chemical Biology. 7(6). 1095–1108. 71 indexed citations
18.
Frohn, Mike, Victor J. Cee, Brian A. Lanman, et al.. (2011). Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. Bioorganic & Medicinal Chemistry Letters. 22(1). 628–633. 9 indexed citations
19.
Frohn, Mike, Vellarkad N. Viswanadhan, Alexander J. Pickrell, et al.. (2008). Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5023–5026. 22 indexed citations
20.
Torres, Gonzalo E., et al.. (1997). Expression of the preoptic regulatory factor-1 and −2 genes in rat testis. Endocrine. 6(1). 65–72. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026